地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：15172469628
传真：15172469628
邮箱：sales@amyjet.com
艾美捷科技代理InSCREENeX品牌全系列产品
InSCREENeX GmbH成立于2009年，位于德国布伦瑞克亥姆霍兹感染研究中心内，是一家专注于开发细胞筛选技术的德国生物技术公司，InSCREENeX生产用于药物开发的细胞系统。InSCREENeX在该领域拥有超过15年的哺乳动物细胞基因修饰专业知识，在此期间成功开发了SCREENflex和CI-SCREEN这两项高度创新的技术。
利用SCREENflex技术，可以根据客户需求创建稳定的重组哺乳动物细胞。这种方法具有以下优势：快速建立所需的测试系统、目标基因的稳定表达，以及能够以不同水平调控该基因的表达。SCREENflex 技术具有普适性，已成功应用于建立多种蛋白质类别，例如 GPCRs（G蛋白偶联受体）、离子通道、抗体和细胞因子。InSCREENeX公司的产品包括稳定表达细胞系、永生化细胞系以及细胞培养试剂。
▍InSCREENeX产品线
● 稳定表达细胞系：包括离子通道、GPCRs、整合素及其他受体的稳定过表达细胞系
| 品名 | 货号 | Target | Cell background |
| CHO-Nav1.8 | INS-SF-1003 | human Nav1.8 plus beta subunit 1 | CHO |
| CHO-Nav1.7 | INS-SF-1037 | human Nav1.7 | CHO |
| CHO-PD-L1 | INS-SF-1028 | human PD-L1 | CHO |
| CHO-EpCAM | INS-SF-1027 | human EpCAM | CHO |
| CHO-PDCD1 | INS-SF-1026 | human PDCD1 | CHO |
| CHO-BCMA | INS-SF-1025 | human BCMA | CHO |
| CHO-B7H3 | INS-SF-1019 | B7H3 | CHO |
| HEK293-CTLA4 | INS-SF-1014 | CTLA4 | HEK293 |
| CHO-CTLA4 | INS-SF-1013 | CTLA4 | CHO |
| HEK293-CXCR4 | INS-SF-1006 | CXCR4 | HEK293 |
| CHO-CXCR4 | INS-SF-1004-L | CXCR4 | CHO |
| CHO-CXCR4 | INS-SF-1004-MH | CXCR4 | CHO |
| HEK293-CXCR7 | INS-SF-1009 | CXCR7 | HEK293 |
| CHO-CXCR7 | INS-SF-1007-L | CXCR7 | CHO |
| CHO-CXCR7 | INS-SF-1007-MH | CXCR7 | CHO |
| HEK293-FOLR1 | INS-SF-1018 | FOLR1 | HEK293 |
| CHO-FOLR1 | INS-SF-1017 | FOLR1 | CHO |
| HEK293-HER2 | INS-SF-1012 | HER2 | HEK293 |
| CHO-HER2 | INS-SF-1010-MH | HER2 | CHO |
| CHO-HER2 | INS-SF-1010-H | HER2 | CHO |
| HEK293-TACD2 | INS-SF-1016 | TACD2 | HEK293 |
| CHO-TACD2 | INS-SF-1015 | TACD2 | CHO |
| HEK293-FAP | INS-SF-1001 | FAP | HEK293 |
| HEK293-CCR8 | INS-SF-1024 | CCR8 | HEK293 |
| CHO-CCR8 | INS-SF-1023 | CCR8 | CHO |
● 永生化细胞系：来自不同物种的功能性永生化细胞系。
| 品名 | 货号 | Species | Organ/Tissue |
| CI-pNaEC | INS-CI-1029 | porcine | Nasal epithel |
| CI-muMEC | INS-CI-1004 | murine | Vascular endothel |
| CI-muHepa | INS-CI-1012 | murine | Liver, hepatocytes |
| CI-muINTEPI | INS-CI-1007 | murine | Intestinal epithel (fetal) |
| CI-muADINTESTI | INS-CI-1018 | murine | Intestinal epithel (adult) |
| CI-huThyrEC | INS-CI-1017 | human | Thyroid epithel |
| CI-huVEC | INS-CI-1002 | human | Endothel, Umbilical vein |
| CI-huOB | INS-CI-1005 | human | Osteoblasts |
| CI-huMEC | INS-CI-1008 | human | Microvascular endothel |
| CI-huFIB | INS-CI-1010 | human | Fibroblasts |
| CI-huEGC | INS-CI-1030 | human | Enteric glial cells (intestine) |
| CI-huBroBEC | INS-CI-1025 | human | Lung, bronchial epithel |
| CI-hAELVi | INS-CI-1015 | human | Lung, Alveoli |
| CI-huArlo | INS-CI-1031 | human | Lung, Alveoli |
● Reagents and Consumables产品
| 分类 | 品名 | 货号 | 规格 |
| Culture Media | CHO Growth Medium A | INS-ME-1039 | 500 ml |
| Culture Media | CHO Growth Medium B | INS-ME-1040 | 500 ml |
| Culture Media | FasTEER Medium | INS-ME-1032-100 | 100 ml |
| Culture Media | HEK293 Growth Medium A | INS-ME-1041 | 500 ml |
| Culture Media | huAEC Medium | INS-ME-1013-100 | 100 ml |
| Culture Media | huAEC Medium | INS-ME-1013-500 | 500 ml |
| Culture Media | huBroBEC Medium | INS-ME-1033 | 500 ml |
| Culture Media | huEGC Medium | INS-ME-1027 | 500 ml |
| Culture Media | huFIB Medium | INS-ME-1001 | 500 ml |
| Culture Media | huMEC Medium | INS-ME-1012 | 500 ml |
| Culture Media | huOB Differentiation Medium | INS-ME-1007 | 100 ml |
| Culture Media | huOB Maintenance Medium | INS-ME-1006 | 500 ml |
| Culture Media | huThyrEC Medium | INS-ME-1017 | 500 ml |
| Culture Media | huVEC Medium | INS-ME-1011 | 500 ml |
| Culture Media | muADINTESTI Medium | INS-ME-1023 | 500 ml |
| Culture Media | muINTEPI Medium | INS-ME-1005 | 500 ml |
| Culture Media | muMEC Medium | INS-ME-1004 | 500 ml |
| Culture Media | pNaEC Medium | INS-ME-1038 | 500 ml |
| Coating Solutions | Coating Solution | INS-SU-1026 | 50ml;100ml;300ml |
| Freezing Media | Cell Freezing Medium | INS-SU-1027 | 30 ml |
▍InSCREENeX提供的服务
● Landing Pad Cells：将目标单拷贝整合到CHO、HEK293 和 Llama主细胞系中，快速生成细胞系并进行变体库整合。
● Random Integration：通过病毒或非病毒方法将目标基因随机整合到任何细胞系中。
● Cell culture services：高度定制化的细胞系服务，包括细胞库构建、细胞存储、制备：细胞沉淀(Pellets)、细胞裂解液(Lysates)、DNA、RNA、培养基优化，原代细胞分离与分选等。
● Assay services：建立并运行检测方法，包含检测方法建立与优化，代运行检测服务等。
● Molecular biology services：包含克隆构建，质粒制备，DNA/RNA分离提取与制备，慢病毒生产等服务。
" data-original="http://fluorochrome.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理InSCREENeX品牌全系列产品"> 艾美捷科技代理InSCREENeX品牌全系列产品
艾美捷科技代理Chromtech品牌全系列产品
Chromtech是专注于色谱分离技术的一家公司，主营色谱耗材、分析仪器及实验室解决方案，服务制药、环保、食品检测等领域。
▍Chromtech主要产品
● 液相色谱（HPLC）配件：包括液相色谱管路、连接接头、无卡套接头、超高效液相接头、液相仪器替换部件、溶剂过滤器，切换阀等；
● 液相色谱柱：包括通用液相色谱柱以及Agilent等代理品牌相关色谱柱；
● 样品瓶与微孔板：包括液相专用样品瓶、原生聚丙烯96孔板以及96孔板用玻璃内嵌管等；
● 样品前处理：针式过滤器、HLB固相萃取吸附剂、硅藻土萃取柱，氮吹仪等；
● 仪器设备：包含液相色谱泵、柱温箱、气体发生器以及全自动前处理平台；
● 气相色谱（GC）产品：包含气相色谱柱、气体泄漏检测仪、电子流量计，GC专用试剂等；
● 进样器具：包含液相微量进样针、气相微量进样针、移液器以及微升600自动稀释仪。
艾美捷科技代理ReVacc Scientific品牌
ReVacc Scientific为科学发现、临床诊断和疾病治疗提供可靠的病毒学和免疫学产品和服务。
▍ReVacc Scientific公司产品
● 假病毒：带有报告基因（如荧光素酶）的假病毒，为样本高通量筛选提供了高效的解决方案。基于多种技术平台，ReVacc Scientific生产针对冠状病毒、丝状病毒或高致病性禽流感病毒的假病毒。
● 重组蛋白：公司专注于生产带有关键中和表位的蛋白质，这些蛋白质应用在疫苗、诊断和治疗三大重要领域。核心优势有：使用真核表达系统（哺乳/昆虫细胞）确保获得正确的翻译后修饰；生产的蛋白质能正确组装成其天然的多聚体状态（如二聚体、三聚体）。
● 单克隆抗体：大多数抗体具有中和活性，具有阻断病原体感染细胞的能力。
● 检测试剂盒：用于检测人、小鼠或兽医动物样本中的 IgG 或抗原水平，操作简便。
● 克隆工具：一步法高效组装；一分钟高效转化。
▍ReVacc Scientific公司服务
● 样本中和抗体效价评估：在符合生物安全要求的前提下，为您测定样本的中和活性；
● 定制化蛋白生产：根据需求生产携带特定突变的定制化蛋白；
● 定制化假病毒构建：根据需求生产携带特定突变的定制化假型病毒。
● 诊断试剂盒定制开发：根据需求开发定制试剂盒
● 定制化抗体发现：开发了多色表位特异性单细胞分选技术 (MESCS®)，并结合重组单克隆抗体技术，从不同物种样本中发掘有价值的抗体。
● 抗体工程化改造：抗体人源化、抗体标记、抗体核苷酸序列测定、抗体同种型转换抗体格式转换以及抗体种属转换。
● 流式细胞分选服务：用于分选具有特定光散射和荧光特性的细胞群。
▍ReVacc Scientific部分产品列表
| 分类 | 品名 | 货号 | 规格 |
| Pseudovirus Reporter | VSV-Pseudovirus_SARS-CoV-2 WT (Wuhan Strain) Spike with luciferase reporter | P14N41 | 200 μl；1000 μl |
| Pseudovirus Reporter | Pseudovirus_RSV Fusion with Luciferase Reporter (A2 strain) | P11A48 | 200 μl；1000 μl |
| Pseudovirus Reporter | Lenti-Pseudovirus_SARS-CoV-2 (Wuhan Strain) Spike with luciferase reporter | O21F29 | 1.1ml;5.5ml |
| Pseudovirus Reporter | VSV-Pseudovirus_MERS-CoV Spike with luciferase reporter | T53L53 | 200 μl；1000 μl |
| Pseudovirus Reporter | VSV-Pseudovirus_SARS-CoV (2003 strain) Spike with luciferase reporter | V44X39 | 200 μl；1000 μl |
| Monoclonal Antibody | Anti-Dengue E Domain III Monoclonal Neutralizing Antibody | K34Q76 | 100 μg；500 μg |
| Monoclonal Antibody | Anti-Ebola Broad Neutralizing Antibody | P5N48 | 100 μg；500 μg |
| Monoclonal Antibody | Anti-HCV E2 Neutralizing Monoclonal Antibody | X81H49 | 100 μg；500 μg |
| Monoclonal Antibody | Anti-Herpes Simplex Virus gD Antibody | Y48B93 | 100 μg；500 μg |
| Monoclonal Antibody | Recombinant Human Anti-hMPV Fusion IgM Antibody | R7V27 | 20 μg；100 μg |
| Monoclonal Antibody | Recombinant Human Anti-hMPV Fusion IgA Antibody | A89X2 | 20 μg；100 μg |
| Recombinant Protein | Dengue virus 1 E protein | R22F8 | 100 μg；500 μg |
| Recombinant Protein | Ebola Sudan GP protein | B78A28 | 100 μg；500 μg |
| Recombinant Protein | Ebola Zaire Makona GP protein | P54P89 | 100 μg；500 μg |
| Recombinant Protein | Herpes simplex virus (HSV) gD protein (Type 1) | L61Q82 | 100 μg；500 μg |
| Recombinant Protein | HIV-1 Trimeric GP140 protein-clade B, YU2 strain | W44H24 | 100 μg；500 μg |
| Test kit | Human Kallikrein 3/PSA Quantitative ELISA (Ultra-sensitive) | S64N86 | 96-well |
| Test kit | Human Anti-Cytomegalovirus gB Protein Antibody IgG Titer Serologic Assay Kit | W19V42 | 96-well |
| Test kit | Human Anti-Dengue Antibody IgG Titer Serologic Assay Kit (E) | P76A64 | 96-well |
| Test kit | Human Anti-Ebola Antibody IgG Titer Serologic Assay Kit (Trimeric GP) | P78G86 | 96-well |
| Test kit | Human Anti-HIV-1 Antibody IgG Titer Serologic Assay Kit (Trimeric GP140) | R29T18 | 96-well |
| Cloning | Seamless Assembly Master Mix (2X) | Q72R56 | 50μl; 250μl;1ml |
| Cloning | One-Minute Competent Cells (Stbl2 similar) | L86Z19 | 8 x 50 μl; 96 x 50 ul |
| Cloning | One-Minute Competent Cells (DH5 Alpha) | L2A1 | 8 x 50 μl; 96 x 50 ul |
艾美捷科技代理Cali-Bio品牌。
Cali-Bio成立于 2009 年，总部位于美国加利福尼亚州，是一家专注于为生命科学研究和生物制药行业提供高质量试剂、细胞培养工具和相关服务的公司。Cali-Bio公司专注于开发和生产高质量的生物试剂和细胞培养工具，产品涵盖细胞培养基、血清、生长因子、细胞分离试剂和定制服务等。Cali-Bio 的产品被广泛应用于细胞生物学、免疫学、癌症研究、干细胞研究和生物制药等领域。Cali-Bio公司主要产品包括：
（1）细胞培养基
经典培养基，提供 DMEM、RPMI-1640、MEM 等常用培养基。
无血清培养基，适用于特定细胞类型的无血清培养，减少批次间差异。
干细胞培养基，支持干细胞的自我更新和分化。
（2）血清和补充剂
胎牛血清（FBS），高质量胎牛血清，适用于多种细胞培养。
马血清、人血清，用于特定细胞类型的培养。
生长因子和细胞因子，包括 EGF、FGF、IGF 等，支持细胞生长和功能维持。
（3）细胞分离和传代试剂
胰酶和细胞解离试剂，用于细胞传代和单细胞分离。
细胞冻存液，提供高效的细胞冻存解决方案，确保细胞存活率。
（4）细胞检测和分析工具
细胞活力检测试剂，如 MTT、CCK-8 等，用于评估细胞活力和增殖。
细胞凋亡检测试剂，用于检测细胞凋亡和坏死。
细胞迁移和侵袭实验试剂，支持癌症研究和药物筛选。
<| 产品名称 | 货号 | 化学式 | 分子量 | CAS# |
| 2,5-Anhydro-6-azido-6-deoxy-1,3-O-isopropylidene-D-glucitol | S20031 | C9H15N3O4 | 229,23 | N/A |
| 4-Azido-4-deoxy-1,6:2,3-dianhydro-β-D-mannopyranose | S97085 | C7H9N3O2 | 167,17 | N/A |
| Methyl-3,6-anhydro-7-azido-2,7-dideoxy-4,5-O-isopropylidene-D-alloheptonate | S10191 | C11H17H3O5 | 271,27 | N/A |
| 1,4-Anhydro-3-azido-2-O-benzoyl-3-deoxy-D-xylitol | S10192 | C12H13N3O4 | 263,25 | N/A |
| 1,4-Anhydro-2-azido-3-O-benzoyl-2-deoxy-D-arabitol | S10189 | C12H13N3O4 | 263,25 | N/A |
| 2-Azido-2-deoxy-1,4;3,6-dianhydro-D-glucitol | S03293 | C6H9N3O3 | 171,15 | N/A |
| 6-Azido-6-deoxy-1,2,3,4-tetra-O-acetyl-α,β-D-galactopyranose | S05174 | C14H19N3O9 | 373,32 | N/A |
| 6-Azido-6-deoxy-1,2,3,4-tetra-O-acetyl-α,β-L-galactopyranose | S02174 | C14H19N3O9 | 373,32 | N/A |
| DIBMA free acid | D-20054 | N/A | N/A | N/A |
| DIBMA monosodium salt | D-20055 | N/A | N/A | N/A |
| Glyco-DIBMA | D-20056 | N/A | N/A | N/A |
| n-Octyl α-D-glucopyranoside (aOG) > 99% highly purified | D97011 | C14H28O6 | 292,38 | 29781-80-4 |
| Methyl 6-O-(-n-heptylcarbamoyl)-α-D-glucopyranoside (HECAMEG) | D20034 | C15H29NO7 | 335,4 | 115457-83-5 |
| n-Hexyl β-D-glucopyranoside > 99% highly purified | D99014 | C12H24O6 | 264,4 | 59080-45-4 |
| n-Heptyl β-D-glucopyranoside (HeptG) > 99% highly purified | D07033 | C13H26O6 | 278,4 | 78617-12-6 |
| n-Octyl β-D-glucopyranoside (OG) > 99% highly purified | D97001 | C14H28O6 | 292,38 | 29836-26-8 |
| n-Octyl β-D-glucopyranoside (OG-C) > 99,5% for crystallography | D97001-C | C14H28O6 | 292,38 | 29836-26-8 |
| n-Nonyl β-D-glucopyranoside (NG) > 99% highly purified | D99011 | C15H30O6 | 306,40 | 69984-73-2 |
| n-Nonyl β-D-glucopyranoside (NG-C) > 99,5% for crystallography | D99011-C | C15H30O6 | 306,40 | 69984-73-2 |
| n-Decyl β-D-glucopyranoside (DG) > 99% highly purified | D99006 | C16H32O6 | 320,43 | 58846-77-8 |
| n-Undecyl β-D-glucopyranoside (UDG) > 99% highly purified | D11023 | C17H34O6 | 334,4 | 70005-86-6 |
| n-Dodecyl β-D-glucopyranoside (DDG) > 99% highly purified | D99007 | C18H36O6 | 348,5 | 59122-55-3 |
| 4-trans-(4-trans-Propylcyclohexyl)-cyclohexyl α-maltoside > 99% (t-PCCαM) | D99019-C | C27H47O11 | 547,67 | N/A |
| n-Dodecyl α-maltoside (αDDM) > 99% highly purified | D99020 | C24H46O11 | 510,63 | 116183-64-3 |
| n-Hexyl β-maltoside (HexM) > 99% highly purified | D20018 | C18H34O11 | 426,4 | 870287-95-9 |
| n-Heptyl β-maltoside (HeptM) > 99% highly purified | D14001 | C19H36O11 | 440,48 | N/A |
| n-Octyl β-maltoside (OM) > 99% highly purified | D20020 | C20H38O11 | 454,4 | 82494-08-4 |
| n-Nonyl β-maltoside (NM) > 99% highly purified | D20015 | C21H40O11 | 468,41 | 106402-05-5 |
| n-Nonyl β-maltoside (NM-C) > 99,5% for crystallography | D20015-C | C21H40O11 | 468,41 | 106402-05-5 |
| n-Decyl β-maltoside (DM) > 99% highly purified | D99003 | C22H42O11 | 482,6 | 82494-09-5 |
| n-Decyl β-maltoside (DM-C) > 99,5% for crystallography | D99003-C | C22H42O11 | 482,6 | 82494-09-5 |
| n-Undecyl β-maltoside (UDM) > 99% highly purified | D99012 | C23H44O11 | 496,6 | 253678-67-0 |
| n-Undecyl β-maltoside (UDM-C) > 99,5% for crystallography | D99012-C | C23H44O11 | 496,6 | 253678-67-0 |
| n-Dodecyl β-maltoside (DDM-C) > 99,5% for crystallography | D97002-C | C24H46O11 | 510,63 | 69227-93-6 |
| n-Tridecyl β-maltoside (TDM) > 99% | D20016 | C25H48O11 | 524,6 | 93911-12-7 |
| n-Tridecyl β-maltoside (TDM-C) > 99,5% for crystallography | D20016-C | C25H48O11 | 524,6 | 93911-12-7 |
| n-Tetradecyl β-maltoside (TeDM-C) > 99,5% for crystallography | D20028-C | C26H50O11 | 538,6 | 18449-82-6 |
| n-Pentadecyl β-maltoside (PDM-C) > 99,5% for crystallography | D20040-C | C27H52O11 | 552,35 | N/A |
| n-Hexadecyl β-maltoside (HeDM) > 99,5% | D20029-C | C28H54O11 | 566,72 | 98064-96-1 |
| n-Dodecyl β-maltoside (DDM) > 99% highly purified | D97002 | C24H46O11 | 510,63 | 69227-93-6 |
| Isopropyl 1-thio-β-D-galactopyranoside (IPTG) | S02122 | C9H18O5 | 238,30 | 367-93-1 |
| n-Heptyl 1-thio-β-D-glucopyranoside (HTG) > 99% highly purified | D99013 | C13H26O5S | 294,4 | 85618-20-8 |
| n-Octyl 1-thio-β-D-glucopyranoside (OTG) > 99% highly purified | D20014 | C14H28O5S | 308,44 | 85618-21-9 |
| n-Nonyl 1-thio-β-D-glucopyranoside (NTG-C) > 99,5% highly purified | D14038-C | C15H30O5S | 322,4 | 98854-15-0 |
| n-Decyl 1-thio-β-D-glucopyranoside (DTG) > 99% highly purified | D20021 | C16H32O5S | 336,4 | 98854-16-1 |
| n-Dodecyl 1-thio-β-maltoside (DDTM-C) > 99,5% highly purified | D20022-C | C24H46O10S | 526,6 | 148565-58-6 |
| n-Heptyl 1-thio-β-D-glucopyranoside (HTG-C) > 99,5% highly purified | D99013-C | C13H26O5S | 294,4 | 85618-20-8 |
| n-Octyl 1-thio-β-D-glucopyranoside (OTG-C) > 99,5% highly purified | D20014-C | C14H28O5S | 308,44 | 85618-21-9 |
| MEGA-8 (N-Octanoyl-N-methylglucamin) | D98004 | C15H31NO6 | 321,4 | 85316-98-9 |
| MEGA-9 (N-Nonanoyl-N-methylglucamin) | D99005 | C16H33NO6 | 335,4 | 85261-19-4 |
| MEGA-10 (N-Decanoyl-N-methylglucamin) | D99008 | C16H33NO6 | 335,4 | 85261-19-4 |
| 1-O-(n-Octyl)-tetraethyleneglycol (C8E4) | D20038 | C16H34O5 | 306,44 | 19327-39-0 |
| 1-O-(n-Decyl)-hexaethyleneglycol (C10E6) | D20041 | C22H46O7 | 422,60 | 5168-89-8 |
| 1-O-(n-Decyl)-nonaethyleneglycol (C10E9) | D20033 | C28H58O10 | 554,75 | 26183-52-81 |
| 1-O-(n-Dodecyl)-tetraethyleneglycol (C12E4) | D20035 | C20H42O5 | 362,54 | 5274-68-0 |
| 1-O-(n-Dodecyl)-octaethyleneglycol (C12E8) | D20039 | C28H58O9 | 538,75 | 3055-98-9 |
| 1-O-(n-Dodecyl)-nonaethyleneglycol (C12E9) | D20032 | C30H62O10 | 582,81 | 3055-99-0 |
| 1-O-(n-Dodecyl)-decaethyleneglycol (C12E10) | D20031 | C32H66O11 | 626,86 | 6540-99-4 |
| 1-O-(n-Tridecyl)-octaethyleneglycol (C13E8) | D20030 | C29H60O9 | 552,78 | 9043-30-5 |
| N,N-Dimethyl-n-dodecylamine-N-oxide (LDAO) | D71111 | C14H31NO | 229,4 | 1643-20-5 |
| Sucrose monolaurate (SUMOL) | S98001 | C24H44NO12 | 524,6 | 25339-99-5 |
| Monoolein (1-O-Oleoyl-rac-glycerol) | D20036 | C21H40O4 | 356,5 | 111-03-5 |
| 3-[(3-Cholamidopropyl)-dimethylammonio]-1-propane sulfonate | D99009 | C32H58N2O7S | 614,89 | 75621-03-3 |
| 3-[(3-Cholamidopropyl)-dimethylammonio]-2-hydroxy-1-propane sulfonate | D99010 | C32H58N2O8S | 630,87 | 82473-24-3 |
| n-Nonyl-phosphocholine (C9-PC) Purity > 99% | S10197 | C14H32NO4P | 309,38 | 253678-64-7 |
| n-Decyl-phosphocholine (C10-PC) Purity > 99% | S10195 | C15H34NO4P | 323,41 | 70504-28-8 |
| n-Undecyl-phosphocholine (C11-PC) Purity > 99% | S10196 | C16H36NO4P | 337,4 | 253678-65-8 |
| n-Dodecyl-phosphocholine (C12-PC) Purity > 99% | S10190 | C17H38NO4P | 351,46 | 29557-51-5 |
| n-Tridecyl-phosphocholine (C13-PC) Purity > 99% | S10198 | C18H40NO4P | 365,49 | 85775-42-4 |
| n-Tetradecyl-phosphocholine (C14-PC) Purity > 99% | S10194 | C19H42NO4P | 379,51 | 77733-28-9 |
| n-Pentadecyl-phosphocholine (C15-PC) Purity > 99% | S10199 | C20H44NO4P | 393,54 | 146801-07-2 |
| n-Hexadecyl-phosphocholine (C16-PC) Purity > 99% | S01241 | C21H46NO4P | 407,57 | 58066-85-6 |
| α-D-Galactopyranose-phosphate di-potassium salt dihydrate | P0001 | C6H11K2O9P. 2H2O | 372,36 | 19046-60-7 |
| α-D-Glucopyranose-phosphate di-potassium salt dihydrate | P0002 | C6H11K2O9P. 2H2O | 372,36 | 5996-14-5 |
| α-D-Mannopyranose-phosphate di-potassium salt dihydrate | P0003 | C6H11K2O9P. 2H2O | 372,36 | 71888-67-0 |
| N-Acetyl-D-galactosamine (2-Acetamido-2-deoxy-D-galactose, GalNAc) | S96001 | C8H15NO6 | 221,21 | 1811-31-0 |
| N-Acetyl-D-glucosamine (2-Acetamido-2-deoxy-D-glucose, GlcNAc) | S93002 | C8H15NO6 | 221,21 | 7512-17-6 |
| 2-Acetamido-2-deoxy-β-D-glucopyranosylamin | S98003 | C8H16N2O5 | 220,21 | 18615-50-4 |
| N-Acetyl-D-mannosamine x H2O (2-Acetamido-2-deoxy-D-mannose monohydrate, D-ManAc x H2O) | S94004 | C8H17NO7 | 239,23 | 7772-94-3 |
| 1,3,4,6-tetra-O-acetyl-β-D-GlcNAc (2-Acetamido-2-deoxy-1,3,4,6-tetra-O-acetyl-β-D-glucopyranose) | S94005 | C16H23NO10 | 389.36 | 7772-79-4 |
| 3,4,6-tri-O-acetyl-β-D-GlcNAc azide (2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-β-D-glucopyranosyl azide) | S96006 | C14H20N4O8 | 372,34 | 6205-69-2 |
| 3,4,6-tri-O-acetyl-α-D-GlcNAc chlorid (2-Acetamido-2-deoxy-3,4,6-tri-O-acetyl-2-deoxy-α-D-glucopyranosyl chlorid) | S97007 | C14H20CINO8 | 366,80 | 3068-34-6 |
| 1,3,4,6-tetra-O-acetyl-α-D-glucosamine x HCl (2-Amino-2-deoxy-1,3,4,6-tetra-O-acetyl-α-D-glucopyranose HCl) | S00116 | C14H22CINO9 | 383,79 | N/A |
| Allyl 2-acetamido-2-deoxy-α-D-glucopyranoside | S96008 | C11H19NO6 | 261,28 | 54400-75-8 |
| Allyl 2-acetamido-2-deoxy-β-D-glucopyranoside | S96009 | C11H19NO6 | 261,28 | 54400-77-0 |
| Allyl α-D-galactopyranoside | S96010 | C9H16O6 | 220,22 | 48149-72-0 |
| Allyl α-D-glucopyranoside | S98011 | C9H16O6 | 220,22 | 7464-56-4 |
| Allyl β-D-glucopyranoside | S98012 | C9H16O6 | 220,22 | 34384-797 |
| Allyl α-D-mannopyranoside | S11118 | C9H16O6 | 220,22 | 41308-76-3 |
| Allyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside | S98013 | C30H34O6 | 490,60 | N/A |
| 1-Amino-1-deoxy-β-D-galactose (β-D-Galactopyranosylamine) | S99102 | C6H13NO5 | 179,17 | 50444-86-5 |
| 1,6-Anhydro-β-D-galactopyranose | S93014 | C6H10O5 | 162,14 | 644-76-8 |
| 1,6:3,4-Dianhydro-2-O-tosyl-β-D-galactopyranose | S97016 | C13H14O6s | 234,25 | 6167-32-4 |
| D-Arabinose | S93017 | C5H10O5 | 150,13 | 28697-53-2 |
| Arbutin (4-Hydroxyphenyl b-D-glucopyranoside, synthetic) | S96018 | C12H16O7 | 272,25 | 497-76-7 |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α-D-galactopyranose | S96021 | C14H19N3O9 | 373,32 | N/A |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α,β-D-galactopyranose | S97022 | C14H19N3O9 | 373,32 | N/A |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-β-D-glucopyranose | S96024 | C14H19N3O9 | 373,32 | N/A |
| 2-Azido-2-deoxy-1,2‘,3,3‘,4‘,6,6‘-hepta-O-acetyl-α,β-lactose 2-Azido-2-deoxy-4-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-1,3,6-tri-O-acetyl-α,β-D-glucopyranose | S96025 | C26H35N3O17 | 661,58 | N/A |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α-D-mannopyranose | S97026 | C14H19N3O9 | 373,32 | N/A |
| Benzyl 4,6-O-benzylidene-α-D-GlcNAc | S97027 | C22H25NO6 | 399,45 | 13343-63-0 |
| Benzyl α-D-GlcNAc (Benzyl 2-acetamido-2-deoxy-α-D-glucopyranoside) | S97028 | C15H21NO6 | 311,34 | 13343-62-9 |
| Benzyl α-D-mannopyranoside | S97029 | C13H18O6 | 270,28 | 155548-45-5 |
| Cellobiose | S96030 | C12H22O11 | 342,30 | 528-50-7 |
| 6-Deoxy-1,2:3,4-di-O-isopropylidene-α-D-galactopyranose | S96032 | C12H20O5 | 244,29 | 4026-27-1 |
| 3,4-Di-O-acetyl-L-rhamnal (3,4-Di-O-acetyl-6-deoxy-L-glucal) | S94035 | C10H14O5 | 214.22 | 34819-86-8 |
| 1,4:3,6-Dianhydro-D-mannitol | S97037 | C6H10O4 | 146,15 | 641-74-7 |
| 1,2,3,4-Di-O-isopropylidene-α-D-galactopyranose | S95038 | C12H20O6 | 260.29 | 4064-06-6 |
| 1,2:5,6-Di-O-isopropylidene-α-D-glucofuranose | S00112 | C12H20O6 | 260,29 | 582-52-5 |
| 1,2:5,6-Di-O-isopropylidene-D-mannitol | S95039 | C12H22O6 | 262,31 | 1707-77-3 |
| 2,3:5,6-Di-O-isopropylidene-α-D-mannofuranose | S93040 | C12H20O6 | 260.29 | 14131-84-1 |
| 1,2:3,5-Di-O-isopropylidene-α-D-xylofuranose | S00110 | C11H18O5 | 230,26 | 20881-04-3 |
| D-Fucose (6-Deoxy-D-galactose) | S96042 | C6H12O6 | 164,16 [3615-37-0] | 3615-37-0 |
| L-Fucose (6-Deoxy-L-galactose) | S96043 | C6H12O6 | 164,16 | 2438-80-4 |
| D-Galactosamine x HCl | S95044 | C6H13NO5 x HCl | 215.64 | 1172-03-8 |
| D-Glucosamine x HCl | S93045 | C6H13NO5 x HCl | 215.64 | 66-84-2 |
| L-Glucose | S94046 | C6H12O6 | 180.16 | 921-60-8 |
| 2,3,3’,4,6,6’-Hexa-O-acetyl-lactal | S97036 | N/A | N/A | |
| 1,2-O-Isopropylidene-α-D-glucofuranose | S00113 | C9H16O6 | 220,22 | 18549-40-1 |
| Isopropyl-β-D-thiogalactoside IPTG (lactose based) | S02122-L | C9H18O5S | 238,31 | 367-93-1 |
| Isopropyl-β-D-thiogalactoside IPTG (on plant based) | S02122-P | C9H18O5S | 238,31 | 367-93-1 |
| 3,4-O-Isopropylidene-D-mannitol | S94048 | C9H18O6 | 222,22 | 369-84-4 |
| 1,2-O-Isopropylidene-α-D-xylofuranose | S00111 | C8H14O5 | 190,20 | 20031-21-4 |
| D-Lyxose | S96051 | C5H10O5 | 150,13 | 1114-34-7 |
| L-Lyxose | S96052 | C5H10O5 | 150,13 | 1949-78-6 |
| Maltose monohydrate | S98053 | C12H22O11H2O | 360,32 | 6363-53-7 |
| β-Maltose octaacetate | S98054 | C28H38O19 | 678,63 | 22352-19-8 |
| D-Mannose | S93057 | C6H12O6 | 180.16 | 3458-28-4 |
| L-Mannose | S94058 | C6H12O6 | 180.16 | 10030-80-5 |
| Methyl 4,6-O-benzylidene-β-D-galactopyranoside | S96060 | C14H18O6 | 282,30 | 6988-39-2 |
| Methyl 4,6-O-benzylidene-α-D-glucopyranoside | S97061 | C14H18O6 | 282,30 | 3162-96-7 |
| Methyl 4,6-O-benzylidene-β-D-glucopyranoside | S98062 | C14H18O6 | 282,30 | 6988-39-2 |
| Methyl 6-deoxy-α-L-mannopyranoside (Methyl a-L-rhamnopyranoside) | S96063 | C7H14O5 | 178,19 | 15814-59-2 |
| Methyl α-D-fucopyranoside | S96064 | C7H14O5 | 178,19 | 1128-40-1 |
| Methyl α-L-fucopyranoside | S96065 | C7H14O5 | 178,19 | 14687-15-1 |
| Methyl β-D-galactopyranoside | S96066 | C7H14O6 | 194,18 | 1824-94-8 |
| Methyl β-D-glucopyranoside hemihydrate | S96067 | C7H14O6 | 194,18 | 7000-27-3 |
| Methyl β-D-ribopyranoside | S97068 | C6H12O5 | 164,16 | 17289-61-1 |
| Methyl 2,3,5-tri-O-benzoyl-α-D-arabinofuranoside | S98069 | C27H24O8 | 476,49 | N/A |
| 1,2,3,4,6-Penta-O-acetyl-β-D-galactopyranose | S95072 | C16H22O11 | 390,35 | 4163-60-4 |
| 1,2,3,4,6-Penta-O-acetyl-α-D-mannopyranose | S99070 | C16H22O11 | 390,35 | 4163-65-9 |
| D-Raffinose pentahydrate | S96074 | C18H32O16 5H2O | 594,53 | 17629-30-0 |
| L-Rhamnose monohydrate | S94075 | C6H14O6 | 182.17 | 10030-85-0 |
| D-Ribose | S93076 | C5H10O5 | 150.13 | 50-69-1 |
| L-Ribose | S93077 | C5H10O5 | 150.13 | 24259-59-4 |
| D-Tagatose | S93079 | C6H12O6 | 180.16 | 87-81-0 |
| α-D-Talose | S93080 | C6H12O6 | 180.16 | 2595-98-4 |
| 2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl azide | S96081 | C14H19N3O9 | 373,32 | 13992-26-2 |
| 2,3,4,6-Tetra-O-acetyl-α-D-galactopyranosyl bromide | S96082 | C14H19BrO9 | 411.21 | 3068-32-4 |
| 2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl azide | S96083 | C14H19N3O9 | 373,32 | 13992-25-1 |
| 2,3,4,6-Tetra-O-acetyl-α-D-glucopyranosyl bromide | S94084 | C14H19BrO9 | 411.21 | 572-09-8 |
| 1,3,4,6-Tetra-O-acetyl-β-D-mannopyranose | S97086 | C14H20O10 | 348,31 | 18968-05-3 |
| 2,3,4,6-Tetra-O-acetyl-α-D-mannopyranose | S97087 | C14H20O10 | 348,31 | N/A |
| 1,2,3,5-Tetra-O-acetyl-β-D-ribofuranose | S94088 | C13H18O9 | 318.28 | 13035-61-5 |
| 2,3,4,6-Tetra-O-acetyl-1-thio-β-D-galactopyranose | S94089 | C14H20O9S | 364.37 | N/A |
| 2,3,4,6-Tetra-O-acetyl-1-thio-β-D-glucopyranose | S94090 | C14H20O9S | 364.37 | 19879-84-6 |
| 2,3,4,6-Tetra-O-benzyl-α-D-galactopyranose | S96091 | C34H3606 | 540.66 | 5308-25-7 |
| 2,3,4,6-Tetra-O-benzyl-α-D-glucopyranose | S93092 | C34H3606 | 540.66 | 4132-28-9 |
| 2,3,4,6-Tetra-O-benzyl-α-D-mannopyranose | S96093 | C34H3606 | 540.66 | 61330-61-8 |
| 1-Thio-β-D-galactose sodium salt | S96094 | C6H11NaO5S | 218,21 | 42891-22-5 |
| 1-Thio-β-D-glucose sodium salt dihydrate | S94095 | C6H11NaO5S x 2 H2O | 254.24 | 10593-29-0 |
| 3,4,6-Tri-O-acetyl-D-galactal | S94097 | C12H16O7 | 272.26 | 4098-06-0 |
| D-Turanose (α-D-Glcp(1-3)-D-fructose) | S93100 | C12H22O11 | 342.30 | 547-25-1 |
| D-Xylose | S93101 | C5H10O5 | 150.13 | 58-86-6 |
| 1,6-Anhydro-β-D-glucopyranose (Levoglucosan) | S93015 | C6H10O5 | 162,14 | 498-07-7 |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α-D-glucopyranose | S96023 | C14H19N3O9 | 373,32 | N/A |
我们承诺：
（1）专业的服务：为您提供包括购买咨询、技术支持及实验方案制定在内的全方位服务；
（2）迅捷的货期：利用国际化的物流平台，大大缩短产品从厂家到最终用户的时间；
（3）过硬的品质：确保正品、质量和售后，多年客户积累，口碑保证。
公司简介：
艾美捷科技有限公司经营范围涵盖分子生物学试剂、免疫学试剂、细胞生物学试剂、蛋白质研究试剂、微生物学试剂、化学及生化试剂、材料学试剂、天然提取物、仪器设备等9大门类，累计约10万余种产品，充分满足不同客户的个性化需求；公司代理国外50余种一线品牌试剂，以“高性价比、迅捷的物流速度、专业的技术支持”，让客户充分享受全球化带来的便利；公司还增加了基因编辑、蛋白表达、细胞鉴定等定制项目，大大提升了为客户服务能力。“不忘初心，方得始终”，艾美捷科技将继续秉持“专心、专业、为您”的宗旨，以客户为根本，以诚信为基础，持续地为各界客户提供更加优质的产品和服务。
Glycon Biochemicals GmbH; Glycon Biochem; Glycon; S20031; S97085; S10191; S10192; S10189; S03293; S05174; S02174; D-20054; D-20055; D-20056; D97011; D20034; D99014; D07033; D97001; D97001-C; D99011; D99011-C; D99006; D11023; D99007; D99019-C; D99020; D20018; D14001; D20020; D20015; D20015-C; D99003; D99003-C; D99012; D99012-C; D97002-C; D20016; D20016-C; D20028-C; D20040-C; D20029-C; D97002; S02122; D99013; D20014; D14038-C; D20021; D20022-C; D99013-C; D20014-C; D98004; D99005; D99008; D20038; D20041; D20033; D20035; D20039; D20032; D20031; D20030; D71111; S98001; D20036; D99009; D99010; S10197; S10195; S10196; S10190; S10198; S10194; S10199; S01241; P0001; P0002; P0003; S96001; S93002; S98003; S94004; S94005; S96006; S97007; S00116; S96008; S96009; S96010; S98011; S98012; S11118; S98013; S99102; S93014; S97016; S93017; S96018; S96021; S97022; S96024; S96025; S97026; S97027; S97028; S97029; S96030; S96032; S94035; S97037; S95038; S00112; S95039; S93040; S00110; S96042; S96043; S95044; S93045; S94046; S97036; S00113; S02122-L; S02122-P; S94048; S00111; S96051; S96052; S98053; S98054; S93057; S94058; S96060; S97061; S98062; S96063; S96064; S96065; S96066; S96067; S97068; S98069; S95072; S99070; S96074; S94075; S93076; S93077; S93079; S93080; S96081; S96082; S96083; S94084; S97086; S97087; S94088; S94089; S94090; S96091; S93092; S96093; S96094; S94095; S94097; S93100; S93101; S93015; S96023; 10030-80-5; 10030-85-0; 10593-29-0; 106402-05-5; 106402-05-5; 111-03-5; 1114-34-7; 1128-40-1; 115457-83-5; 116183-64-3; 1172-03-8; 13035-61-5; 13343-62-9; 13343-63-0; 13992-25-1; 13992-26-2; 14131-84-1; 146801-07-2; 14687-15-1; 148565-58-6; 155548-45-5; 15814-59-2; 1643-20-5; 1707-77-3; 17289-61-1; 17629-30-0; 1811-31-0; 1824-94-8; 18449-82-6; 18549-40-1; 18615-50-4; 18968-05-3; 19046-60-7; 19327-39-0; 1949-78-6; 19879-84-6; 20031-21-4; 20881-04-3; 22352-19-8; 24259-59-4; 2438-80-4; 25339-99-5; 253678-64-7; 253678-65-8; 253678-67-0; 253678-67-0; 2595-98-4; 26183-52-81; 28697-53-2; 29557-51-5; 29781-80-4; 29836-26-8; 29836-26-8; 3055-98-9; 3055-99-0; 3068-32-4; 3068-34-6; 3162-96-7; 34384-797; 3458-28-4; 34819-86-8; 3615-37-0; 367-93-1; 367-93-1; 367-93-1; 369-84-4; 4026-27-1; 4064-06-6; 4098-06-0; 41308-76-3; 4132-28-9; 4163-60-4; 4163-65-9; 48149-72-0; 497-76-7; 498-07-7; 50444-86-5; 50-69-1; 5168-89-8; 5274-68-0; 528-50-7; 5308-25-7; 54400-75-8; 54400-77-0; 547-25-1; 572-09-8; 58066-85-6; 582-52-5; 58846-77-8; 58-86-6; 59080-45-4; 59122-55-3; 5996-14-5; 61330-61-8; 6167-32-4; 6205-69-2; 6363-53-7; 641-74-7; 644-76-8; 6540-99-4; 66-84-2; 69227-93-6; 69227-93-6; 6988-39-2; 6988-39-2; 69984-73-2; 69984-73-2; 7000-27-3; 70005-86-6; 70504-28-8; 71888-67-0; 7464-56-4; 7512-17-6; 75621-03-3; 7772-79-4; 7772-94-3; 77733-28-9; 78617-12-6; 82473-24-3; 82494-08-4; 82494-09-5; 82494-09-5; 85261-19-4; 85261-19-4; 85316-98-9; 85618-20-8; 85618-20-8; 85618-21-9; 85618-21-9; 85775-42-4; 870287-95-9; 87-81-0; 9043-30-5; 921-60-8; 93911-12-7; 93911-12-7; 98064-96-1; 98854-15-0; 98854-16-1
<艾美捷科技代理AxisPharm品牌全系列产品
AxisPharm是一家专业的分析服务提供商，致力于为科学研究界和工业界提供高质量的分析服务。凭借先进的仪器设备和专业的技术团队，AxisPharm在生物分析、化学分析和质量控制领域树立了良好的声誉。AxisPharm公司的产品线包括：PEG 连接子、用于药物递送的脂质、荧光染料、单击化学试剂、聚聚乙二醇，共聚物、可裂解的连接子、抗体和抗体药物偶联物ADC、ADC 有效载荷、细胞生物学试剂、脱氧核糖核酸、修饰语、探针、合成肽、目标特定链接器、硫醇反应性接头、酸反应性连接子、胺反应性连接子、羰基反应性连接子、探针、修饰符。
▍AxisPharm产品线
● PEG连接子：聚合物聚乙二醇是多分散聚乙二醇 （PEG） 聚合物，是一种从石油中提取的聚醚化合物，具有从工业制造到医药的许多应用。
● 用于药物递送的脂质：在药物递送系统中起着至关重要的作用，特别是在脂质体、脂质纳米颗粒或脂质胶束等脂质制剂中。脂质提供结构稳定性，增强药物溶解度，实现控释，并促进靶向药物递送。
● 荧光染料：也称为荧光团或荧光探针，是吸收一种波长的光并以更高波长发射的化合物，从而产生可见荧光。它们是生物学研究中的重要工具，用于标记和检测蛋白质、核酸和细胞等生物分子，从而在显微镜、流式细胞术和实时荧光定量 PCR 等应用中实现灵敏和精确的可视化。
● 点击化学试剂：具有高特异性和最少的副产物，简化了复杂的合成过程。因此，它们在分子生物学、材料科学和药物化学中发挥着至关重要的作用。
● 聚合物聚乙二醇：多分散聚乙二醇 （PEG） 聚合物，是一种从石油中提取的聚醚化合物，具有从工业制造到医药的许多应用。
● 可裂解连接子：一类重要的分子，广泛应用于药物发现、化学生物学和材料科学等各个领域。这些连接子充当两个或多个分子实体之间的连接桥，可以在特定条件下选择性地裂解，从而释放附着的分子。这一特性使它们成为生物活性化合物靶向药物递送、成像和控释的有吸引力的工具。
● 抗体及抗体-药物偶联物及细胞生物学试剂：种类丰富可选择。
● ADC有效载荷：作为 ADC 的三个主要成分之一，有效载荷是高活性和有毒的药物分子，通过化学连接子附着在抗体上。有效载荷可以是小分子、蛋白质毒素、生物活性肽、酶，甚至放射性核素。通过适当的接头与适当的载体系统耦合的有效载荷可能会显示出靶向药物递送的特异性和有效性的提高。
● 脱氧核糖核酸：DNA 是脱氧核糖核酸的缩写，是一种包含所有生物体发育和功能的遗传指令的分子。DNA 由四个基本组成部分组成，称为核苷酸，由糖、磷酸基团和含氮碱基组成。
● 改性剂：改变其他分子或材料特性的化合物。在药物研发领域，改性剂在新型药物递送系统和生物医学设备的设计和优化中发挥着至关重要的作用。一种常见的改性剂类型是官能团，它是赋予分子特定化学和物理性质的原子的特定排列。
● 探针：AxisPharm 提供各种靶标特异性探针，例如叶酸 PEG、生物素 PEG、PROTAC PEG、荧光染料探针和图像探针。探针是一类含有官能团的化合物，旨在选择性地与生物分子（如酶、受体和核酸）相互作用。这些官能团包括荧光染料、生物素和亲和标签等，可以检测和定量复杂生物系统中的特定分子。
| Different Types of Polyethylene Glycol PEG Linkers in Stock | ||||
| Acid PEG | Diketone PEG | Non-PEG linker | PFP ester PEG | Sugar PEG β-Glucuronide Linker |
| Aldehyde PEG | DNP PEG | PEG-t-butyl ester | Phosphonate PEG | Sulfonic acid PEG |
| Alkyne PEG | DBCO PEG | PEG-X-PEG | Polymer PEG | TCO PEG |
| Amino PEG | DSPE PEG | Peptide Linkers | Propargyl PEG | Tetrazine PEG |
| Aminooxy PEG | Fluorescent PEG | Lipid PEG | PROTAC Linker | Homobifunctional PEG |
| Azide PEG | Fmoc PEG | M-PEG | Silane PEG | Bromo PEG |
| BCN-PEG | Folate PEG | Maleimide PEG | SPDP PEG | Tosylate PEG |
| Benzyl-PEG | Thiol PEG | MeNH-PEG | Branched PEG | Bis-Sulfone PEG |
| Biotin PEG | Hydrazide PEG | NHS ester PEG | HyNic PEG | DOTA Reagent DOTA PEG |
| Bis-PEG-acid | Hydroxy PEG | Boc-PEG | Bis-PEG-NHS | Iodo PEG |
| Bis-PEG-NHS | Cleavable Linkers | |||
| Lipids for Drug Delivery | ||||
| Biotinyl Cap PE | Dodecanyl PE | Other Lipid | Phosphatidylcholine | Phosphatidylethanolamine |
| Biotinyl PE | Glutaryl PE | PDP PE | Phosphoglycerol | Ptd Thioethanol |
| Caproylamine PE | Ionizable Lipid | PE MCC | Phosphoserine | Succinyl PE |
| Cationic Lipid | Lipid PEG | Cyanur PE | MPB PE | |
| Fluorescent Dye | ||||
| AF Dyes | Cyanine Dyes | MB Dyes | Rhodamine Dye | Rox (carboxy-X-rhodamine) Dye |
| APDye Fluors | DNP PEG | JOE | R6G | Peptide Labeling Reagents |
| Bodipy Probes | Fluorescein (FAM) | Pyrene Probes | TAMRA Dye | Classic Fluorescent Dyes |
| IR Fluors | Quenchers | Coumarin 343 | ||
| Click Chemistry Tools & Reagents | ||||
| Alkyne PEG | BCN-PEG | PTAD Linker | Tetrazine PEG | Click Chemistry Auxiliary Reagents |
| Azide PEG | DBCO PEG | TCO PEG | Methylcyclopropene Linkers | |
| Polymer PEG | ||||
| Acrylate | Biotin | Fmoc | Lipoamide | Silane |
| Active ester | Boc | Folate | Maleimide | Stearic acid |
| Aldehyde | Carboxylic acid | guanlian1010 | MW 2000 | TCO |
| Amine | Cholesterol | Hydrazide | MW 5000 | Thiol |
| Azide | DBCO | Hydroxyl | Polysarcosine | |
| Cleavable Linkers | ||||
| -S-S-Cleavable | PC Cleavable | Disulfide Linkers | Dde Cleavable Linkers | β-Glucuronide Linkers |
| Cleavable Peptide | diazo biotin probes | DTSSP crosslinker | Photocleavable Biotin | |
| Antibody and Antibody Drug Conjugate (ADC) | ||||
| Inotuzumab | Trastuzumab | Enfortumab | Labetuzumab govitecan | Mirvetuximab soravtansine (solution) |
| Vobramitamab | Disitamab | Mirzotamab | Loncastuximab tesirine | Trastuzumab deruxtecan (solution) |
| Polatuzumab | Ozuriftamab | Brentuximab | Trastuzumab deruxtecan | ADC Control Human IgG1-Deruxtecan (DAR 8) |
| Gemtuzumab | Inebilizumab | Datopotamab | Cofetuzumab pelidotin | Glembatumumab vedotin |
| Daratumumab (PBS) | Denintuzumab | Sacituzumab govitecan | Belantamab mafodotin | Trastuzumab duocarmazine |
| Praluzatamab | Naratuximab | Tisotumab | Enfortumab vedotin-ejfv | Trastuzumab emtansine (solution) |
| Lorvotuzumab | Rolinsatamab | Trastuzumab emtansine | Telisotuzumab vedotin | Enfortumab vedotin-ejfv (solution) |
| Izeltabart | Mipasetamab | Datopotamab deruxtecan | Gemtuzumab ozogamicin | Brentuximab vedotin (solution) |
| Lupartumab | Iladatuzumab | ORM-5029 | Cantuzumab ravtansine | Depatuxizumab mafodotin |
| Cantuzumab | Briobacept | Ifinatamab deruxtecan | Tusamitamab ravtansine | ADC Control Human IgG1-Deruxtecan (DAR 4) |
| Lonigutamab | Tamrintamab | Tisotumab vedotin | Zilovertamab vedotin | Depatuxizumab MMAE |
| Moxetumomab | Sacituzumab | Disitamab vedotin | Polatuzumab vedotin | ADC Control Human IgG1-vcMMAF |
| Azintuxizumab | Upifitamab | Belantamab | Pivekimab | Sacituzumab govitecan (solution) |
| Lifastuzumab | Glembatumumab | Patritumab deruxtecan | Farletuzumab ecteribulin | |
| Payloads and Linker modified Payloads | ||||
| Exatecan | Belotecan HCl | SGD-1882 | Dolastatin 10 | MC-Val-Cit-PAB-Doxorubicin |
| SN 38 | Gimatecan | MMAF | Calicheamicin | Gly3-Val-Cit-PAB-MMAE |
| Amrubicin | Taltobulin | Auristatin E | Eribulin Mesylate | SuO-Glu-Val-Cit-PAB-MMAE |
| Mitomycin C | Dxd | Chlorambucil | Soblidotin (Auristatin PE) | Fmoc-G-amino-CH2O acetyl-Exetecan |
| Deruxtecan analog | Lurtotecan | PF-06380101 | Deruxtecan analog 2 | DM1-MCC-PEG3-Biotin |
| sulfo-SPDB-DM4 | Exatecan mesylate | Auristatin F | Paclitaxel | GGFG-amino-CH2O-acetyl Exetecan |
| Rubitecan | MC-DM1 | MMAF-methyl ester | MC-MMD10 | Mal-PEG8-Val-Cit-PAB-MMAE |
| (4-NH2)-Exatecan | Irinotecan | Doxorubicin-SMCC | SPDB-DM4 | DBCO-PEG4-Val-Cit-PAB MMAF |
| Topotecan | PNU-159682 | MMAD | 10-Hydroxycamptothecin | Topotecan Hydrochloride |
| CL2A-SN38 | DM4 | 7-Ethylcamptothecin | ||
| Cell Biology Reagents | ||||
| Neuro-DiO, lipophilic tracer | VU (5-Vinyl-uridine) | CM-DiI, lipophilic tracer | LumiTracker ER Green | ER-Tracker Red (BODIPY TR Glibenclamide) |
| Annexin V-AF 647 conjugate | DAPI, blue fluorescent nucleic acid stain | Propidium Iodide | Deep-Red Fluorescent Nissl Stain | MitoCLox, mitochondrial lipid peroxidation probe |
| Annexin V-AF 488 conjugate | LumiTracker Mito Rhodamine 123 | LumiTracker Mito Green FM | RAPID DiI, lipophilic tracer | Laurdan (6-Dodecanoyl-2-dimethylaminonaphthalene) |
| Annexin V, His Tag | Thiazole Orange | SynaptoProbe® Red | LumiTracker ER Red | Linear Polyacrylamide for Nucleic Acid Precipitation |
| DiD, lipophilic tracer | RH 237, potentiometric probe | SynaptoProbe® Green | RAPID DiO, lipophilic tracer | Fluo-4 AM, green fluorescent calcium indicator |
| DiR, lipophilic tracer | Hoechst 33342, blue fluorescent nucleic acid stain | LumiTracker® Mito Red FM | DiI, lipophilic tracer | YODi-1, green fluorescent nucleic acid stain |
| DNA | ||||
| CPG solid supports | DNA Stains | Modified Triphosphates | phosphoramidite | |
| Probes | ||||
| Biotin PEG | Folate PEG | Image Probes | PROTAC Linker | |
| Amine reactive Linkers | ||||
| Acid PEG | Aldehyde PEG | Bromo PEG | Maleimide PEG | NHS ester PEG |
▍AxisPharm提供的服务
● 蛋白质组学服务：提供质谱分析、蛋白质鉴定和定量服务。专注于生物标志物分析，帮助客户在复杂的生物样本中发现和验证潜在的生物标志物。
● 代谢组学服务：利用先进的LC-MS/MS技术进行代谢物分析，提供通路洞察，帮助客户理解代谢途径和生物过程。
● 高级LC-MS/MS服务：用于PK分析和HPLC分离，确保高精度和高效率的研究结果，提供PK/PD研究，支持药物开发和临床前研究。
▍AxisPharm部分产品列表
| Cat# | Name | M.W. | Purity |
| AP15197 | Exatecan | 435.45 | ≥98% |
| AP15072 | SN 38 | 392.4 | ≥95% |
| AP15226 | Amrubicin | 483.47 | ≥98% |
| AP15664 | Mitomycin C | 334.3 | ≥98% |
| AP15203 | 10-Hydroxycamptothecin | 364.35 | ≥95% |
| AP15204 | 7-Ethylcamptothecin | 376.41 | ≥95% |
| AP15210 | Rubitecan | 393.35 | ≥95% |
| AP15211 | (4-NH2)-Exatecan | 403.43 | ≥95% |
| AP15206 | Topotecan | 421.5 | ≥95% |
| AP15207 | Topotecan Hydrochloride | 425.5 | ≥95% |
| AP15202 | Belotecan HCl | 433.5 | ≥95% |
| AP15208 | Gimatecan | 447.5 | ≥95% |
| AP15227 | Taltobulin | 473.65 | ≥99% |
| AP15201 | Dxd | 493.48 | ≥95% |
| AP15209 | Lurtotecan | 518.56 | ≥95% |
| AP15196 | Exatecan mesylate | 531.55 | ≥98% |
| AP15200 | Deruxtecan analog 2 | 579.58 | ≥95% |
| AP15205 | Irinotecan | 586.68 | ≥95% |
| AP15224 | PNU-159682 | 641.62 | ≥98.24% |
| AP15220 | Soblidotin (Auristatin PE) | 701.98 | ≥95% |
| AP15225 | SGD-1882 | 725.8 | ≥98% |
| AP15213 | MMAF | 732 | ≥95% |
| AP15216 | Auristatin E | 732 | ≥95% |
| AP15311 | Chlorambucil | 304.21 | ≥98 |
| AP15219 | PF-06380101 | 743.01 | ≥95% |
| AP15214 | Auristatin F | 746 | ≥95% |
| AP15215 | MMAF-methyl ester | 745.99 | ≥98% |
| AP15187 | Doxorubicin-SMCC | 762.8 | ≥98% |
| AP15217 | MMAD | 771.06 | ≥98% |
艾美捷科技代理Abliance品牌全系列产品
Abliance是一家法国的抗体制造商和服务提供商，由专家组成的团队，在细胞培养、蛋白质工程和质量控制方面拥有深厚专业知识，专注为体外诊断（IVD）及科研领域提供高合规性抗体解决方案，满足研究和诊断工业市场的抗体需求。
▍Abliance公司产品提供丰富可选择的抗体库
| 多物种来源 | 多特异性靶点 | 多样标记方式 | 多级适用品质 |
| anti-human Ig | anti-IgG, IgM, IgA | fluorescent | globulins |
| anti-mouse and rabbit Ig | anti-IgGAM | enzymatic | affinity purified antibodies |
| anti-goat, bovine, dog Ig ... | anti-Fc and Fab fragments | biotin | Fab and F(ab')2 fragments |
● Abliance的二抗产品为多克隆抗体，通过使用人或动物免疫球蛋白对实验动物（兔、山羊或绵羊）进行高效免疫后获得。收集的免疫血清除含有目标特异性抗体外，还包含非特异性抗体及血清杂蛋白。
● Globulins：经过系列非特异性纯化步骤（脱脂处理→硫酸铵沉淀→透析）后获得球蛋白组分，此中间产物适用于免疫沉淀技术。
● Affinity purified antibodies：随后通过亲和层析对抗体进行纯化，从而确保高特异性。此外，抗鼠/兔IgG（H+L）二抗需在装有人源IgA/IgG/IgM的凝胶层析柱上进行系统化吸附处理，确保其与人源IgA/IgG/IgM无交叉反应。
● Fragments：Abliance提供经酶切获得的F(ab')₂和Fab片段，适用于免疫组化/细胞学检测及流式细胞术等场景。相较于含Fc区的完整抗体，这些片段能显著降低非特异性结合。其更小的分子量可增强细胞和组织渗透性。
● Labeled antibodies：Abliance供应多样标记物复合体：球蛋白组分、纯化抗体及Fab/F(ab')₂片段，可与荧光染料（异硫氰酸荧光素）、酶类（过氧化物酶、碱性磷酸酶、β-半乳糖苷酶、葡萄糖氧化酶）及生物素进行偶联。
▍Abliance部分产品列表
| 货号 | 品名 | 规格 | Host | Antigen |
| BI 1014 | Anti-Human IgGAM Globulin | 4mg/2ml | Goat | Human IgGAM |
| BI 1015 | Anti-Human IgG (H+L) Globulin | 4mg/2ml | Goat | Human IgG (H+L) |
| BI 1016 | Anti-Human IgA (alpha) Globulin | 4mg/2ml | Goat | Human IgA (alpha) |
| BI 1018 | Anti-Human IgG (gamma) Globulin | 4mg/2ml | Goat | Human IgG (gamma) |
| BI 1019 | Anti-Human IgM (µ) Globulin | 4mg/2ml | Goat | Human IgM (µ) |
| BI 1025 | Anti-Human albumin Globulin | 4mg/2ml | Goat | Human albumin |
| BI 3014 | Anti-Human IgGAM Fab | 2mg/1ml | Goat | Human IgGAM |
| BI 3015 | Anti-Human IgG (H+L) Fab | 2mg/1ml | Goat | Human IgG (H+L) |
| BI 3016 | Anti-Human IgA (alpha) Fab | 2mg/1ml | Goat | Human IgA (alpha) |
| BI 3018 | Anti-Human IgG (gamma) Fab | 2mg/1ml | Goat | Human IgG (gamma) |
| BI 3019 | Anti-Human IgM (µ) Fab Goat | 2mg/1ml | Goat | Human IgM (µ) |
| BI 3025 | Anti-Human albumin Fab | 2mg/1ml | Goat | Human albumin |
| BI 4015 | Anti-Human IgG (H+L) F(ab')2 | 2mg/1ml | Goat | Human IgG (H+L) |
| BI 4016 | Anti-Human IgA (alpha) F(ab')2 | 2mg/1ml | Goat | Human IgA (alpha) |
| BI 4018 | Anti-Human IgG (gamma) F(ab')2 | 2mg/1ml | Goat | Human IgG (gamma) |
| BI 4019 | Anti-Human IgM (µ) F(ab')2 | 2mg/1ml | Goat | Human IgM (µ) |
| BI 4025 | Anti-Human albumin F(ab')2 | 2mg/1ml | Goat | Human albumin |
| BI 3414 | Anti-Human IgGAM Fab HRP | 1ml | Goat | Human IgGAM |
| BI 3415 | Anti-Human IgG (H+L) Fab HRP | 1ml | Goat | Human IgG (H+L) |
| BI 3416 | Anti-Human IgA (alpha) Fab HRP | 1ml | Goat | Human IgA (alpha) |
| BI 3418 | Anti-Human IgG (gamma) Fab HRP | 1ml | Goat | Human IgG (gamma) |
| BI 3419 | Anti-Human IgM (µ) Fab HRP | 1ml | Goat | Human IgM (µ) |
| BI 3425 | Anti-Human albumin Fab HRP | 1ml | Goat | Human albumin |
| BI 4414 | Anti-Human IgGAM F(ab')2 HRP | 1ml | Goat | Human IgGAM |
| BI 4415 | Anti-Human IgG (H+L) F(ab')2 HRP | 1ml | Goat | Human IgG (H+L) |
| BI 4419 | Anti-Human IgM (µ) F(ab')2 HRP | 1ml | Goat | Human IgM (µ) |
| BI 4425 | Anti-Human albumin F(ab')2 HRP | 1ml | Goat | Human albumin |
艾美捷科技代理Oxford Expression Technologies品牌。
Oxford Expression Technologies（英国）位于英国牛津，为全球制药和生物技术行业提供产品，服务和咨询服务。OET专门从事重组蛋白表达，其核心技术flashBACTM是一种基于杆状病毒
的蛋白表达系统，能快速生产适用于小型和大型蛋白表达系统的多种重组病毒。
OET产品还涉及昆虫和哺乳动物表达系统中的载体、转染试剂和培养基。
< " data-original="http://fluorochrome.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Oxford Expression Technologies品牌"> 艾美捷科技代理Oxford Expression Technologies品牌
Polymun Scientific主要是提供CRO服务和为客户提供脂质体形式的药物研发服务，而且不断地增加产品线，和升级技术平台。Polymun Scientific秉持开放态度，提供研发服务和授权服务。
The two core competences of Polymun are the development and manufacture of biopharmaceuticals using mammalian cell technology as well as Polymun's innovative liposome technology and expertise. Today, Polymun can apply this drug delivery platform to all kinds of pharmaceutically active ingredients. The industrial applicability in scale and price is a common focus throughout all projects and technologies.
Polymun Scientific的主要产品包括：
（1）Biopharmaceuticals
Reference Projects
Technology & Capacities
Services
Analytical Methods
Clinical & Regulatory Support
Patents & Publications
（2）Liposomes
Reference Projects
Technology
Services
Analytical Methods
Clinical & Regulatory Support
Patents & Publications
（3）R&D Projects
Liposomal Superoxide Dismutase
Recombinant Porcine Trypsin
Carbamylated Epo-Fc Fusion Protein
HIV Antibodies
Influenza
（4）Research Reagents
Order Info
HIV Antibodies
HIV Antigens
Recombinant Porcine Trypsin
Test Tubes, Vials, Caps and Closures
Animal Research
Filtration
Incubators, Hot Plates, Baths and Heating
Mixers, Shakers and Stirrers
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
艾美捷科技代理Polysciences品牌。
Polysciences的产品以其高质量和多样性而著称，特别是在聚乙烯亚胺（Polyethylenimine，PEI）转染试剂方面有着显著的优势。Polysciences公司成立于1961年，主要生产和经营生命科学（胶体金、不含甲醛的甲醇等）、病理学和显镜学微球和粒子、磁珠、各种单体和聚体等产品；作为世界上最大最全的多聚化合物供应商，同时也是世界领先的免疫学、组织化学试剂耗材供应商。
Polysciences特色的PEI转染试剂特点包括：
（1）高效性：PEI转染试剂具有高效的瞬转效率和蛋白产量，广泛应用于基因和细胞治疗产品的开发，包括病毒载体和蛋白质工艺开发、临床试验以及商业化生产。
（2）广泛适用性：适用于多种细胞系，如HEK293、CHO、Sf9等，且转染效率高达80%~90%。
（3）升级产品：如PEI MAX 40K，作为第一代PEI 25K的升级产品，其去乙酰化和盐酸盐形式增强了水溶性，提高了转染效率。
产品应用范围包括：
病毒载体开发：可用于生产和优化病毒载体，将基因修饰的病毒载体导入目标细胞内，从而实现基因转染；
重组蛋白表达：可以将编码目标蛋白的基因高效地转入宿主细胞，从而大量表达所需的重组蛋白；
基因编辑技术：如CRISPR-Cas9系统中，PEI转染试剂用于将相关基因编辑组件送入细胞内；
细胞治疗研究：用于提高细胞的治疗效果和生存率，需要将特定的遗传物质传递到细胞内，以改变细胞的行为或增强其治疗效果。
<<<< " data-original="http://fluorochrome.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Polysciences品牌转染试剂"> 艾美捷科技代理Polysciences品牌转染试剂
地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：13212737804
传真：17754422825
邮箱：sales@amyjet.com
0.1648
